CANOF yields 964.60% · PFE yields 6.13%● Live data
📍 CANOF pulled ahead of the other in Year 1
Combined, CANOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CANOF + PFE for your $10,000?
California Nanotechnologies Corp. engages in the research, development, and production of nano-structured components and materials. The company provides spark plasma sintering (SPS); cryogenic milling; SPS/fast tooling; wire electrical discharge machining; planetary milling and particle size analysis; hot pressing tooling fabrication and design; tensile, compression, and hardness testing; planetary ball milling; V-blending/ tumble milling; particle size analysis through laser diffraction; and metals and metallic alloys machining services. It also offers SPS starter accessory kits, SPS graphite tooling, spark plasma sintering machines, tungsten carbide tooling, SPS graphite crucibles, carbon graphite foil/paper, carbon felt, and yarn and quartz glass windows. It serves microchip fabrication, aerospace, sports and recreation, defense, automotive, medical, and the oil and gas industries. The company is headquartered in Cerritos, California.
Full CANOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.